COVID-19 Vaccine Frontrunners
COVID-19 Vaccine Frontrunners
Four vaccine candidates—two in the US, one in China, and one in the UK—have been approved for early testing in people. Several others are close on their heels.
COVID-19 Vaccine Frontrunners
COVID-19 Vaccine Frontrunners

Four vaccine candidates—two in the US, one in China, and one in the UK—have been approved for early testing in people. Several others are close on their heels.

Four vaccine candidates—two in the US, one in China, and one in the UK—have been approved for early testing in people. Several others are close on their heels.

drug development
Infographic: Researchers Take Aim at Cancer Evolution
Infographic: Researchers Take Aim at Cancer Evolution
Catherine Offord | Apr 1, 2020
Strategies to trick, manipulate, and direct the evolution of tumors
Infographic: Building Bacteria to Fight Cancer
Infographic: Building Bacteria to Fight Cancer
Simone Schuerle, Tal Danino | Apr 1, 2020
Researchers are engineering microbes to deliver therapeutics specifically to tumors, maximizing the treatments’ efficacy while minimizing side effects.
Bacteria as Living Microrobots to Fight Cancer
Bacteria as Living Microrobots to Fight Cancer
Simone Schuerle, Tal Danino | Apr 1, 2020
Autonomous, living microrobots that seek and destroy cancer are not as futuristic as one might imagine, thanks to a fusion of robotics and synthetic biology.
Cancer Researchers Use Evolution to Target Drug Resistance
Cancer Researchers Use Evolution to Target Drug Resistance
Catherine Offord | Apr 1, 2020
New therapeutic approaches in oncology aim to manipulate or block cancer’s adaptation to treatment.
COVID-19 Vaccine Developers Gain Enhanced Access to Supercomputers
COVID-19 Vaccine Developers Gain Enhanced Access to Supercomputers
Lisa Winter | Mar 27, 2020
Federal agencies, academic institutions, and industrial partners are joining forces to combat COVID-19 using artificial intelligence.
Opinion: Stop Private Speculation in COVID-19 Research
Opinion: Stop Private Speculation in COVID-19 Research
Emiliano Brancaccio, Ugo Pagano | Mar 23, 2020
We present an economic plan for a collective sharing of scientific knowledge on the pandemic.
Clinical Trial of COVID-19 Vaccine Begins in Seattle
Clinical Trial of COVID-19 Vaccine Begins in Seattle
Amy Schleunes | Mar 16, 2020
The first volunteer will receive a shot of the synthetic RNA vaccine today.
Scientists Use Online Game to Research COVID-19 Treatment
Scientists Use Online Game to Research COVID-19 Treatment
Emma Yasinski | Mar 9, 2020
The creativity of citizen scientists could help researchers design proteins that may be able to fight the SARS-CoV-2 virus.
How Aripiprazole’s Promise for Treating Autism Fell Short
How Aripiprazole’s Promise for Treating Autism Fell Short
Hannah Furfaro | Feb 27, 2020
Aripiprazole, marketed as Abilify, is widely thought to be safer than risperidone, the only other drug approved for use in autistic children. A decade’s worth of data suggests that is not true.